National Research Corporation
HealthcareNASDAQ:NRC · NASDAQ Global Select
+$0.00 today
Vol 0.09M · Avg 0.11M
Management
Put operating results in leadership context
Review returns on capital, executive background, insider transactions, and growth quality to judge whether management is compounding value well.
Return Metrics
ROE, ROIC & ROA over time
ROE
82.9%
avg 63.8%
ROIC
14.4%
avg 30.2%
ROA
8.6%
avg 21.3%
Analysis
ROE is currently the strongest return metric at 82.9% versus its period average of 63.8%. 3 of 3 return metrics are above their quality threshold, which helps indicate how efficiently the company turns capital and assets into profit.
Management
Key executives, compensation & ownership
| Name | Title | Compensation | Tenure | Age | Shares Owned | Ownership % |
|---|---|---|---|---|---|---|
Trent Green | CEO, Principal Executive Officer & Director | $5.70M | — | 54 | $500,000.00 | 2.22% |
Helen L. Hrdy | EVP & COO | $1.23M | — | 61 | $0.00 | <0.01% |
Andrew Monnich | EVP & Chief Corporate Development Officer | $1.23M | — | 50 | $100,000.00 | 0.44% |
Jason R. Rau | Executive Vice President of Sales | $619,133.00 | — | 55 | $60,000.00 | 0.27% |
Shane R. Harrison | Executive VP, CFO, Treasurer & Secretary | $447,347.00 | — | 49 | $8,000.00 | 0.04% |
Michael D. Hays | Founder & Chairman | $308,222.00 | — | 71 | $0.00 | <0.01% |
Jason Rau | Executive Vice President | — | — | — | $60,000.00 | 0.27% |
David Burik | Executive Vice President of Strategic Insights | — | — | 68 | $100,000.00 | 0.44% |
Jennifer Baron | Chief Experience Officer | — | — | — | — | — |
Jordan N. Freeman | Chief Accounting Officer | — | — | 38 | $771.00 | <0.01% |
Vinitha Ramnathan | Chief Product Officer | — | — | — | — | — |
Insider Trading
SEC Form 4 transactions — last 12 months
Buys
2
$108,162.27
Sells
0
$0.00
Net Sentiment
+$108,162.27
Net buying
Most Active
HARRISON SHANE R
1 transactions
| Date | Insider | Type | Shares | Price | Value | |
|---|---|---|---|---|---|---|
| Feb 17, 2026 | HARRISON SHANE R Indirect | Buy | 8.0K | $12.27 | $98,162.40 | |
| Jul 31, 2025 | Freeman Jordan Nicole Direct | Buy | 771 | $12.97 | $9,999.87 |
Analysis
Insiders reported 2 buys worth $108,162.27 and 0 sells worth $0.00 over the last 12 months. That adds up to net buying of $108,162.27. HARRISON SHANE R was the most active insider with 1 transactions.
Growth Analysis
Historical CAGR & forward analyst estimates
| Metric | 10yr | 5yr | 3yr | Fwd Est. |
|---|---|---|---|---|
| EPS | N/A | N/A | -42.6% | +8.3% (13yr)1 analysts |
| Revenue | N/A | N/A | +5.8% | +1.8% (13yr)1 analysts |
| Net Income | N/A | N/A | +5.3% | +3.0% (13yr)1 analysts |
| EBIT | N/A | N/A | +5.2% | +1.9% (13yr)1 analysts |
Analysis
Recent growth has been strongest in Revenue at +5.8% over three years. Forward estimates point to EPS at +8.3% (13yr), giving you a quick check on whether expectations are accelerating or cooling.
Competitors
Peer companies in the same sector
Viemed Healthcare, Inc.
NASDAQ:VMD
$400.62M
TruBridge, Inc.
NASDAQ:TBRG
$391.78M
Puma Biotechnology, Inc.
NASDAQ:PBYI
$373.09M
SOPHiA GENETICS S.A.
NASDAQ:SOPH
$349.74M
Spok Holdings, Inc.
NASDAQ:SPOK
$227.67M
Quanterix Corporation
NASDAQ:QTRX
$146.03M
Health Catalyst, Inc.
NASDAQ:HCAT
$136.70M
SANUWAVE Health, Inc.
NASDAQ:SNWV
$128.21M
Nano-X Imaging Ltd.
NASDAQ:NNOX
$122.48M
Definitive Healthcare Corp.
NASDAQ:DH
$88.59M
Who manages NRC?
National Research Corporation (NRC) lists 11 active executives. The top listed executive is Shane R. Harrison, Executive VP, CFO, Treasurer & Secretary.
Are NRC insiders buying or selling?
Recent insider activity shows net selling of $97.95M.
Explore More
Continue the stock analysis
Jump to another research area for this company.